Antibioclic Amrita
Amritaclic is a therapeutic decision support tool in antibiotic therapy, intended for AMRITA physicians. Its objective is to allow rational antibiotic therapy, according to the recommendations of AMRITA and INDIA learned societies. For each bacterial pathology frequently encountered in medicine, there is a therapeutic proposal, depending on the patient's profile.
About Us
5 individual variables are systematically suggested by the tool :
- adult
- child
- pregnant
- renal failure
Amritaclic is a pilot CDSS for therapeutic advice, not helping or orientating in any case the diagnostic.
Antibioclic has freely provided the template of CDSS in order to pilot Amritaclic
Amritaclic decision trees and guidelines have been developed by an expert committee, involving clinicians and microbiologists from Amrita Institute of Medical Sciences and abroad:
- Dr Sanjeev Singh, Medical Superintendent, Amrita Institute of Medical Sciences
- Dr Aparna Chakravarty, ID physician, Amrita Institute of Medical Sciences
- Dr Rohit Kumar Garg, ID physician, Amrita Institute of Medical Sciences
- Dr Sadia Khan, Microbiologist, Amrita Institute of Medical Sciences
- Dr Aleena Issac, Clinical pharmacist, Amrita Institute of Medical Sciences
- Ms Fabia Edathadathil, Quantitative Researcher, Amrita Institute of Medical Sciences
Funding:
- Amritaclic was funded through the ASPIRES project for this 4-year project comes from the Economic and Social Research Council (ESRC) and is part of a cross-council initiative encompassing the ESRC’s Global Challenge Research Fund (GCRF) funding allocation. Further information can be found on the UKRI website.
